An endothelin receptor antagonist TAK-044 ameliorates carbon tetrachloride-induced acute liver injury and portal hypertension in rats

Liver

Volumn 18, Issue 1, 1998, Pages 39-48

  Gandhi, Chandrashekhar R ^a   Nemoto, Edwin M ^a   Watkins, Simon C ^b   Subbotin, Vladimir M ^a  

^a UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

^b UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

Author keywords

Antagonist; Cirrhosis; Endothelin; Liver; Portal hypertension

Indexed keywords

CARBON TETRACHLORIDE; ENDOTHELIN 1; ENDOTHELIN RECEPTOR; ENDOTHELIN RECEPTOR ANTAGONIST; LIVER ENZYME; TAK 044;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; INTRAVENOUS DRUG ADMINISTRATION; LIVER CIRRHOSIS; LIVER INJURY; LIVER LEVEL; LIVER NECROSIS; MALE; MORPHOLOGY; NONHUMAN; PORTAL HYPERTENSION; PORTAL VEIN BLOOD PRESSURE; RAT;

EID: 0031932430     PISSN: 01069543     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1600-0676.1998.tb00125.x     Document Type: Article

References (61)

1. YANAGISAWA M, MASAKI T. Functional studies on endothelin catch up with molecular biology. Trends Pharmacol Sci 1989; 10: 374-8.
2. GANDHI C R, BERKOWITZ D E, WATKINS W D. Endothelins: biochemistry and pathophysiologic actions. Anesthesiology 1994; 80: 892-905.
3. RIEDER H, RAMADORI G, MEYER ZUM BUSECHENFELDE KH. Sinusoidal endothelial liver cells in vitro release endothelin - augmentation by transforming growth factor β and Kupffer cell-conditioned media. Klin Wochenschr 1991; 69: 387-91.
4. 125I]endothelin-1 by liver-derived cells. Arch Biochem Biophys 1993; 305: 38-46.
5. GANDHI C R, BEHAL R B, HARVEY S A K, NOUCHI T A, OLSON M S. Hepatic effects of endothelin: receptor characterization and endothelin-induced signal transduction in hepatocytes. Biochem J 1992; 287: 897-904.
6. HOUSSET C, ROCKEY D C, BISSELL D M Endothelin receptors in rat liver: lipocytes as a contractile target for endothelin 1 Proc Natl Acad Sci USA 1993; 90: 9266-70.
7. GANDHI C R, STEPHENSON K, OLSON M S. Endothelin, a potent peptide agonist in the liver. J Biol Chem 1990; 265: 17432-5.
8. TRAN-THI T A, KAWADA N, DECKER K. Regulation of endothelin-1 action on the perfused rat liver. FEBS Lett 1993; 318: 353-7.
9. SERRADEIL-LE GAL C, JOUNEAUX C, SANCHEZ-BUENO A, et al. Endothelin action in rat liver. J Clin Invest 1991; 87: 133-8.
10. GANDHI C R, STEPHENSON K, OLSON M S. A comparative study of endothelin- and platelet-activating factor-mediated signal transduction and prostaglandin synthesis in rat Kupffer cells. Biochem J 1992; 281: 485-92.
11. MUSTAFA S B, GANDHI C R, HARVEY S A K, OLSON M S. Endothelin stimulates platelet-activating factor synthesis by cultured rat Kupffer cells. Hepatology 1995; 21: 545-53.
12. PINZANI M, FAILLI P, RUOCCO C, et al. Fat-storing cells as liver-specific pericytes. Spatial dynamics of agonist-stimulated intracellular calcium transients. J Clin Invest 1992; 90: 642-6.
13. KAWADA N, TRAN-THI T A, KLEIN H, DECKER K. The contraction of hepatic stellate (Ito) cells stimulated with vasoactive substances. Possible involvement of endothelin 1 and nitric oxide in the regulation of the sinusoidal tonus. Eur J Biochem 1993; 213: 815-23.
14. SAKAMOTO M, UENO T, KIN M, et al. Ito cell contraction in response to endothelin-1 and substance P. Hepatology 1993; 18: 978-83
15. ZHANG J X, PEGOLI W JR, CLEMENS M G. Endothelin-1 induces direct constriction of hepatic sinusoids. Am J Physiol 1994; 266: G624-G632.
16. MOORE K, WENDON J, FRAZER M, KARANI J, WILLIAMS R, BADR K Plasma endothelin immunoreactivity in liver disease and the hepatorenal syndrome. New Eng J Med 1992; 327: 1774-8.
17. UEMASU J, MATSUMOTO H, KAWASAKI H. Increased plasma endothelin levels in patients with liver cirrhosis. Nephron 1992; 60: 380.
18. PITTET J-F, MOREL D R, HEMSEN A. et al. Elevated plasma endothelin-1 concentrations are associated with the severity of illness in patients with sepsis. Ann Surg 1991; 213: 261-4.
19. MOREL D R, LECROIX J S, HEMSEN A, STEINIG D A, PITTET J-F, LUNDBERG J M. Increased plasma and pulmonary lymph levels of endothelin during endotoxin shock. Eur J Pharmacol 1989; 167: 427-8.
20. LERMAN A, CLICK R L, NARR B J, et al. Elevation of plasma endothelin associated with systemic hypertension in humans following orthotopic liver transplantation. Transplantation 1991; 51: 646-50.
21. NANJI A A, KHWAJA S, KHETTRY U, SADRZADEH S M. Plasma endothelin levels in chronic ethanol fed rats: relationship to pathologic liver injury. Life Sci 1994; 54: 423-8.
22. OSHITA M, TAKEI Y, KAWANO S, et al. Roles of endothelin-1 and nitric oxide in the mechanism for ethanol-induced vasoconstriction in rat liver. J Clin Invest 1993; 91: 1337-42.
23. HALIM A, KANAYAMA N, MAEHARA K, TAKAHASHI M, TERAO T. HELLP syndrome-like biochemical parameters obtained with endothelin-1 injections in rabbits. Gynecol Obstetr Invest 1993; 35: 193-8.
24. BLUHM R E, FRAZER M G, VORE M, PINSON C W, BADR K F. Endothelins-1 and -3: potent cholestatic agents secreted and excreted by the liver that interact with cyclosporine. Hepatology 1993; 18: 961-8.
25. GANDHI C R, SPROAT L A, SUBBOTIN V M. Increased hepatic endothelin-1 levels and endothelin receptor density in cirrhotic rats. Life Sci 1996; 58: 55-62.
26. GANDHI C R, KANG Y, DE WOLF A, et al. Altered endothelin homeostasis in patients undergoing liver transplantation. Liver Transplant Surg 1996; 2: 362-9.
27. KUSUMOTO K, FUJIWARA A, IKEDA S, WATANABE T, FUJINO M. Pharmacological characterization of cardiovascular responses induced by endothelin-1 in the perfused rat heart. Eur J Pharmacol 1996; 296: 65-74.
28. TAKAYANAGI R, KITAZUMI K, TAKASAKI C, et al. Presence of non-selective type of endothelin receptor on vascular endothelium and its linkage to vasodilation. FEBS Lett 1991; 282: 103-6.
29. WILLIAMS JR D L, JONES K L, PETTIBONE D J, LIS E V, CLINESCHMIDT B V. Sarafotoxin S6c: an agonist which distinguishes between endothelin receptor subtypes. Biochem Biophys Res Commun 1991; 175: 556-61.
30. SLATER T F. Free radical mechanisms in tissue injury. London: Pion Ltd., 1972.
31. GOTO M, TAKEI Y, KAWANO S, et al. Endothelin-1 is involved m the pathogenesis of ischemia/reperfusion liver injury by hepatic microcirculatory disturbances Hepatology 1994; 19: 675-81.
32. NAKAMURA S, NISHIYAMA R, SERIZAWA A, et al. Hepatic release of endothelin-1 after warm ischemia. Transplantation 1995; 59: 679-84.
33. OKUMURA S, TAKEI Y, KAWANO S, et al. Vasoactive effect of endothelin-1 on rat liver in vivo. Hepatology 1994; 19: 155-61.
34. GABRIEL A, WATKINS W D, GANDHI C R. Superoxide-induced up-regulation of endothelin (ET) receptors and stimulation of ET-1 synthesis in hepatic fat-storing Ito cells. FASEB J 1996; 10: 3360 (abstract).
35. DRATH D B, KARNOVSKY M L. Superoxide production by phagocytic leukocytes. J Exp Med 1975; 141: 257-62.
36. JOHNSTON JR, R B, GODZIK C A, COHN Z A. Increased Superoxide anion production by immunologically activated and chemically elicited macrophages. J Exp Med 1978; 148: 115-27.
37. MARKERT M, FREI J. The respiratory burst in human polymorphonuclear leukocytes stimulated by particles. Adv Exp Med Biol 1982; 141: 383-92.
38. ROSSI F, BELLAVITE P, BERTON G, DRI P, ZABUCCHI G. The respiratory burst of phagocytic cells: facts and problems. Adv Exp Med Biol 1982; 141: 283-322.
39. WEENING R S, WEVER R, ROOS D. Quantitative aspects of the production of Superoxide radicals by phagocytizing human granulocytes. J Lab Clin Med 1975; 85: 245-52.
40. SHIRATORI Y, TAKIKAWA H, KAWASE T, SUGIMOTO T. Superoxide anion generating capacity and lysosomal enzyme activities of Kupffer cells in galactosamine induced hepatitis. Gastroenterol Jpn 1986; 21: 135-44.
41. SIES H ed. Oxidative stress. London: Academic Press, 1985.
42. KITAYAMA Y, YAMANAKA N, KAWAMURA E, KURODA N, OKAMOTO E. Hepatoprotective effect of the endothelin receptor antagonist TAK-044 against ischemia-reperfusion injury in the canine liver. Hepatology 1997; 25: 936-42.
43. JIN M B, TODO S, ZHU Y, et al. Attenuation of ischemic liver injury by a non-selective endothelin receptor antagonist. Transplantation Proc 1997; 29: 1335.
44. BHATHAL P S, GROSSMAN H J. Reduction of the increased portal vascular resistance of the isolated perfused cirrhotic rat liver by vasodilators. J Hepatol 1985; 1: 325-37.
45. ROCKEY D C, WEISIGER R A. Endothelin induced contractility of stellate cells from normal and cirrhotic rat liver: implications for regulation of portal pressure and resistance. Hepatology 1996; 24: 233-40.
46. NAKATA K, SHIBAYAMA Y, Hepatic vascular resistance in liver cirrhosis. In: TSUCHIYA M, ASANO M, MISHIMA Y, ODA M eds. Microcirculation - an update, Vol 2. New York: Elsevier, 1987; 339-44.
47. SIMS D E. The pericyte - a review. Tissue Cell 1986; 18: 153-74.
48. GEERTS A, DEBLESER P, HAUTEKEETE M L, NIKI T, WISSE E. Fat-storing (Ito) cell biology. In: ARIAS I M, BOYER J L, FASUTO N, JAKOBY W B, SCHACHTER D L, SHAFRITZ D A, eds. The liver: biology and pathobiology. New York: Raven Press Ltd, 1994; 819-38.
49. BACHEM M G, MELCHIOR R J, GRESSNER A M. Activation of perisinusoidal lipocytes (transdifferentiation into myofibroblast-like cells) is stimulated by transforming growth factor β1 (TGF-β1) and tumor necrosis factor α (TNF-α). In: GRESSNER AM, RAMADORI G, eds. Molecular and cell biology of liver fibrogenesis. Dordrecht: Kluwer Academic Publishers, 1992; 262-70.
50. 125I-endothelin-1 to fat-storing cells in rat liver revealed by electron microscopic radioautography. Anat Embryol 1992; 185: 97-100.
51. PINZANI M, MILANI S, DEFRANCO R, et al. Endothelin 1 is overexpressed in human cirrhotic Ever and exerts multiple effects on activated hepatic stellate cells. Gastroenterology 1996; 110: 534-48.
52. MASAKI T, VANE JR, VANHOUTTE P M. International Union of Pharmacology nomenclature of endothelin receptors. Pharmacol Rev 1994; 46: 137-42.
53. KURIHARA T, AKIMOTO M, KUROKAWA K, et al. ET-3 sensitive reduction of tissue blood flow in rat liver. Life Sci 1992; 51: PL101-PL106.
54. ROCKEY D C. Characterization of endothelin receptors mediating rat hepatic stellate cell contraction. Biochem Biophys Res Commun 1995; 207: 725-731.
55. GIAID A, YANAGISAWA M, LANGLEBEN D, et al. Expression of endothelin-1 in the lungs of patients with pulmonary hypertension. New Eng J Med 1993; 328: 1732-9.
56. GIAID A, MICHEL R P, STEWART D J, SHEPPARD M, CORRIN B, HAMID Q. Expression of endothelin-1 in lungs of patients with cryptogenic fibrosing alveolitis. Lancet 1993; 341: 1550-4.
57. MORELLI S, FERRI C, POLETTINI E, et al. Plasma endothelin-1 levels, pulmonary hypertension, and lung fibrosis in patients with systemic sclerosis. Am J Med 1995; 99: 255-60.
58. FINE L G, NORMAN J T, ONG A. Cell-cell cross-talk in renal interstitial fibrosis. Kidney Int 1995; 47: S48-S50.
59. VANCHEESWARAN R, AZAM A, BLACK C, DASHWOOD M R. Localization of endothelin-1 and its binding sites in scleroderma skin. J Rheumatol 1994; 21: 1268-76.
60. PINZANI M, ABBOUD H E. Liver fat-storing cells, polypeptide growth factors and the progression of chronic: liver inflammation and fibrosis. In: GENTILINI P, DIANZINI MU, eds. Amsterdam: Elsevier Science Publishers, 1991; 63-75.
61. ROCKEY D C, CHUNG J J. Endothelin antagonism in experimental hepatic fibrosis. J Clin Invest 1996; 98: 1381-8.